John M.L. Ebos
Impact in
- Modeling and Simulation top 0.5%
- Mathematical Biology Tumor Growth
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Robert S. Kerbel (18 shared papers)Christina R. Lee (11 shared papers)James G. Christensen (4 shared papers)William Cruz‐Muñoz (2 shared papers)Georg Arnold Bjarnason (1 shared paper)Amanda Tracz (9 shared papers)Sébastien Benzekry (7 shared papers)Anthony J. Mutsaers (4 shared papers)
- Journals
- Annals of Surgical Oncology (5 papers)Cancer Research (5 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)PLoS Computational Biology (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
John M.L. Ebos
46 papers receiving 4.4k citations
John M.L. Ebos's Hit Papers
Peers
Comparison fields: 5 of 117
- Modeling and Simulation 471
- Oncology 883
- Molecular Biology 2k
- Cancer Research 425
- Genetics 149
Countries citing papers authored by John M.L. Ebos
This map shows the geographic impact of John M.L. Ebos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M.L. Ebos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M.L. Ebos more than expected).
Fields of papers citing papers by John M.L. Ebos
This network shows the impact of papers produced by John M.L. Ebos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M.L. Ebos. The network helps show where John M.L. Ebos may publish in the future.
Co-authors
The 25 scholars most cited alongside John M.L. Ebos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis Hit paper breakdown → | 2009 | 1487 |
| 2 | Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Hit paper breakdown → | 2011 | 601 |
| 3 | Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth Hit paper breakdown → | 2014 | 410 |
| 4 | 2007 | 324 | |
| 5 | 2009 | 240 | |
| 6 | 2004 | 172 | |
| 7 | 2004 | 140 | |
| 8 | 2014 | 124 | |
| 9 | 2020 | 105 | |
| 10 | 2008 | 100 | |
| 11 | 2017 | 82 | |
| 12 | 2009 | 78 | |
| 13 | Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. | 2002 | 68 |
| 14 | 2010 | 63 | |
| 15 | 2015 | 51 | |
| 16 | 2015 | 50 | |
| 17 | 2020 | 47 | |
| 18 | 2005 | 40 | |
| 19 | 2014 | 37 | |
| 20 | 2005 | 34 |
About John M.L. Ebos
John M.L. Ebos is a scholar working on Oncology, Cancer Research, Modeling and Simulation, Molecular Biology and Immunology, having authored 51 papers that have together received 4.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (20 papers), Breast Cancer Treatment Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Mathematical Biology Tumor Growth (5 papers), Cancer Cells and Metastasis (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Modeling and Simulation (471 citations), Oncology (883 citations), Molecular Biology (2k citations), Cancer Research (425 citations) and Genetics (149 citations). John M.L. Ebos has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Robert S. Kerbel, Christina R. Lee, James G. Christensen, William Cruz‐Muñoz, Georg Arnold Bjarnason, Amanda Tracz, Sébastien Benzekry, Anthony J. Mutsaers, Clare Lamont and Lynn Hlatky. Their work appears in journals such as Annals of Surgical Oncology, Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research and PLoS Computational Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.